CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is one of the most promising tools of contemporary genetic engineering. Previously identified as a defense mechanism against ...

MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we ...

CRISPR Therapeutics (CRSP) reported new preclinical data from its novel SyNTase gene editing platform for the treatment of Alpha-1 Antitrypsin ...

Scientists have worked tirelessly to develop ever more precise and efficient CRISPR-Cas systems to reach the ultimate goal: safe and effective CRISPR-Cas-based medical treatments. Over the years, ...

CRISPR is a gene-editing tool that acts like “molecular scissors,” but using it on cancer is complex. The technology’s biggest impact so far is in research labs, helping scientists understand how ...

Ottawa, July 08, 2025 (GLOBE NEWSWIRE) -- The global CRISPR gene editing market size was valued at USD 4.15 billion in 2024 and is predicted to hit around USD 16.47 billion by 2034, a study published ...

Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a potential best-in-class profile--The AATD ...

Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the global CRISPR-based gene editing market size was estimated at USD 3.06 billion in 2024. It is predicted to surpass ...

Gene editing in plants remains challenging, with the traditional non-homologous end-joining (cNHEJ) repair pathway often ...